EPISODE · Jul 16, 2026 · 16 MIN
Chapter 33, Ep 1 of 5: C. diff Diagnosis and First-Episode Treatment
from Dr GI Joe · host Board Pearls
Episode one of the GI Infections chapter builds C. diff around two competing problems: the defaults moved off metronidazole and vancomycin, and asymptomatic colonization is common enough that the wrong test drives unnecessary treatment. The organizing idea is that diagnosis exists to separate active disease from colonization, while treatment exists to get the right drug to the colonic lumen at the right concentration for the right duration. Severity thresholds decide treatment intensity, and fulminant features bring surgery into the conversation at presentation rather than after medical failure. Everything reduces to those two problems. Topics covered Antibiotic exposure and C. diff risk factors Presentation and pseudomembranous colitis Two-step NAAT plus toxin EIA algorithm Who to test and why test of cure fails Severity stratification thresholds Fidaxomicin first-line and vancomycin alternative Metronidazole in third place and pregnancy Fulminant disease regimen and surgery Key decisions Test only patients with high pre-test probability, three or more unexplained watery stools per day off laxatives, and screen with a sensitive NAAT or GDH before confirming with a specific toxin EIA. Treat a discordant NAAT-positive, toxin-EIA-negative result as likely colonization and correlate clinically rather than reflexively treating, and never send a test of cure. Stratify by white count of fifteen thousand and creatinine of one point five: below both is nonsevere, either threshold is severe, and hypotension, ileus, or megacolon makes it fulminant. Treat a first non-fulminant episode with fidaxomicin two hundred milligrams twice daily for ten days, using oral vancomycin one hundred twenty-five milligrams four times daily when fidaxomicin is unavailable. Never give intravenous vancomycin for C. diff because it does not reach the colonic lumen, and reserve oral metronidazole for the lowest-risk patients only when neither preferred drug is available. Choose oral vancomycin first-line in pregnancy on decades of safety data, and stop the inciting antibiotic as part of treatment. Treat fulminant disease with high-dose oral vancomycin five hundred milligrams every six hours plus intravenous metronidazole, add rectal vancomycin when ileus blocks oral delivery, and engage surgery at presentation. For the full chapter with MCQs, tables, and primary-guideline references, visit www.boardpearls.com. Questions or feedback: [email protected].
What this episode covers
Episode one of the GI Infections chapter builds C. diff around two competing problems: the defaults moved off metronidazole and vancomycin, and asymptomatic colonization is common enough that the wrong test drives unnecessary treatment. The organizing idea is that diagnosis exists to separate active disease from colonization, while treatment exists to get the right drug to the colonic lumen at the right concentration for the right duration. Severity thresholds decide treatment intensity, and fulminant features bring surgery into the conversation at presentation rather than after medical failure. Everything reduces to those two problems. Topics covered Antibiotic exposure and C. diff risk factors Presentation and pseudomembranous colitis Two-step NAAT plus toxin EIA algorithm Who to test and why test of cure fails Severity stratification thresholds Fidaxomicin first-line and vancomycin alternative Metronidazole in third place and pregnancy Fulminant disease regimen and surgery Key decisions Test only patients with high pre-test probability, three or more unexplained watery stools per day off laxatives, and screen with a sensitive NAAT or GDH before confirming with a specific toxin EIA. Treat a discordant NAAT-positive, toxin-EIA-negative result as likely colonization and correlate clinically rather than reflexively treating, and never send a test of cure. Stratify by white count of fifteen thousand and creatinine of one point five: below both is nonsevere, either threshold is severe, and hypotension, ileus, or megacolon makes it fulminant. Treat a first non-fulminant episode with fidaxomicin two hundred milligrams twice daily for ten days, using oral vancomycin one hundred twenty-five milligrams four times daily when fidaxomicin is unavailable. Never give intravenous vancomycin for C. diff because it does not reach the colonic lumen, and reserve oral metronidazole for the lowest-risk patients only when neither preferred drug is available. Choose oral vancomycin first-line in pregnancy on decades of safety data, and stop the inciting antibiotic as part of treatment. Treat fulminant disease with high-dose oral vancomycin five hundred milligrams every six hours plus intravenous metronidazole, add rectal vancomycin when ileus blocks oral delivery, and engage surgery at presentation. For the full chapter with MCQs, tables, and primary-guideline references, visit www.boardpearls.com. Questions or feedback: [email protected].
NOW PLAYING
Chapter 33, Ep 1 of 5: C. diff Diagnosis and First-Episode Treatment
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m